Mara Ortega-Gómez

Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio

R. Costa, C. Suárez, J. Ancochea, 2017, PLoS ONE.

Usefulness of circulating microRNAs miR-146a and miR-16-5p as prognostic biomarkers in community-acquired pneumonia

J. Curbelo, H. de la Fuente, J. Galván-Román, 2020, PloS one.

Neutrophil Count Percentage and Neutrophil–Lymphocyte Ratio as Prognostic Markers in Patients Hospitalized for Community-Acquired Pneumonia

F. Moldenhauer, J. Curbelo, J. Galván-Román, 2019, Archivos de Bronconeumología (English Edition).

The incidence of cardiovascular events after hospitalization due to CAP and their association with different inflammatory markers

C. Suárez, J. Ancochea, J. Curbelo, 2014, BMC Pulmonary Medicine.

Neutrophil Count Percentage and Neutrophil-Lymphocyte Ratio as Prognostic Markers in Patients Hospitalized for Community-Acquired Pneumonia.

F. Moldenhauer, J. Curbelo, J. Galván-Román, 2019, Archivos de bronconeumologia.

Neutrophil Count Percentage and Neutrophil-Lymphocyte Ratio as Prognostic Markers in Patients Hospitalized for Community-Acquired Pneumonia.

F. Moldenhauer, J. Curbelo, J. Galván-Román, 2019, Archivos de bronconeumologia.

Correction: Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio

R. Costa, C. Suárez, J. Ancochea, 2019, PloS one.